Recap: Atea Pharmaceuticals Q4 Earnings
Recap: Atea Pharmaceuticals Q4 Earnings
Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Atea Pharmicals（纳斯达克股票代码：AVIR）于2024年2月28日星期三下午4点05分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Atea Pharmaceuticals beat estimated earnings by 6.0%, reporting an EPS of $-0.47 versus an estimate of $-0.5.
Atea Pharmicals的收益比预期高出6.0％，每股收益为-0.47美元，而预期为-0.5美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.08 which was followed by a 9.0% drop in the share price the next day.
上个季度，该公司的每股收益高出0.08美元，随后第二天股价下跌了9.0％。
To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.
要追踪Atea Pharmaceuticals的所有财报，请在此处访问其财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。